RecruitingPhase 3NCT06961214
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Sponsor: GlaxoSmithKline
Sheffield, AL · +56 more sites
3 recruiting copd studies with a site in Sheffield, AL.
Sponsor: GlaxoSmithKline
Sheffield, AL · +56 more sites
Sponsor: AstraZeneca
Athens, AL · Cullman, AL · Fairhope, AL · +232 more sites
Sponsor: AstraZeneca
Foley, AL · Mobile, AL · Sheffield, AL · +70 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.